Also, the pharmacogenetic study of Scherer’s group presented the correlations of UGT2B4 rs1131878 heterozygotes with lower risk of colorectal cancer in users of nonsteroidal anti-inflammatory drugs than nonusers with only major alleles [45]. Here, UGT2B4 is linked to colorectal cancer.